| 產(chǎn)品名稱 | Human herpesvirus 3 |
|---|---|
| 商品貨號(hào) | B162843 |
| Classification | Herpesviridae, Varicellovirus |
| Agent | Human herpesvirus 3 |
| Strain | Oka |
| Common Name | Varicella zoster virus |
| Applications | Virucide testing In vitro infectivity assay Antiviral Studies Spiking studies ELISpot Assay Virus neutralization assay Virus ultrastructural studies Immunological-based assays PCR-based assay validation Research and development Assay development Vaccine development |
| Biosafety Level | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format | frozen 1.0 mL per vial |
| Storage Conditions | Vapor phase of liquid nitrogen |
| Images |  |
| Comments | Live, attenuated vaccine strain. Thermosensitive compared with other wild type strains. Depositor screened by Neurovirulence safety test, and result was compliant. |
| Effect on Host | CPE, refractile rounding and degenration |
| Recommended Host | MRC-5 cells (ATCC® CCL-171™) |
| Growth Conditions | Temperature: 37°C Recommendations for Infection: Plate cells 16-24 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.01). Adsorb 1-2 hours at 37°C in a humidified x% CO2 atmosphere. End adsorption by adding virus growth medium. Replace virus growth medium at one day post-inoculation to remove DMSO from the culture. Harvest by removing culture medium and adding cell dissociation buffer. Dilute in freeze medium containing a final concentration of 7% DMSO and preserve with a controlled-rate freeze (1°C/minute). Incubation: 3-4 days at 37°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 60% of the monolayer. |
| Source | Y Oyabu, The Research Foundation for Microbial Diseases of Osaka University |
| References | Takahashi M, et al. Development of a live attenuated varicella vaccine. Biken J. 18: 25-33, 1975. PubMed: 167707 |
| 序號(hào) | 文章標(biāo)題 | 操作 |
|---|---|---|
| 1 | ATCC細(xì)胞運(yùn)輸和處理 | 查看詳情 |
| 2 | 其他海外品牌代理 | 查看詳情 |
| 3 | ATCC代理 | 查看詳情 |
| 4 | 購(gòu)買須知 | 查看詳情 |
| 5 | 訂購(gòu)流程 | 查看詳情 |
| 梅經(jīng)理 | 17280875617 | 1438578920 |
| 胡經(jīng)理 | 13345964880 | 2438244627 |
| 周經(jīng)理 | 17757487661 | 1296385441 |
| 于經(jīng)理 | 18067160830 | 2088210172 |
| 沈經(jīng)理 | 19548299266 | 2662369050 |
| 李經(jīng)理 | 13626845108 | 972239479 |
